Pulmonary impairment independently determines mortality in critically ill patients with acute-on-chronic liver failure.

ACLF CLIF-C ACLF score CLIF-C ACLF-R score acute-on-chronic liver failure mechanical ventilation pulmonary failure respiratory failure

Journal

Liver international : official journal of the International Association for the Study of the Liver
ISSN: 1478-3231
Titre abrégé: Liver Int
Pays: United States
ID NLM: 101160857

Informations de publication

Date de publication:
01 2023
Historique:
revised: 26 05 2022
received: 20 03 2021
accepted: 19 06 2022
pubmed: 22 6 2022
medline: 4 1 2023
entrez: 21 6 2022
Statut: ppublish

Résumé

In ACLF patients, an adequate risk stratification is essential, especially for liver transplant allocation, since ACLF is associated with high short-term mortality. The CLIF-C ACLF score is the best prognostic model to predict outcome in ACLF patients. While lung failure is generally regarded as signum malum in ICU care, this study aims to evaluate and quantify the role of pulmonary impairment on outcome in ACLF patients. In this retrospective study, 498 patients with liver cirrhosis and admission to IMC/ICU were included. ACLF was defined according to EASL-CLIF criteria. Pulmonary impairment was classified into three groups: unimpaired ventilation, need for mechanical ventilation and defined pulmonary failure. These factors were analysed in different cohorts, including a propensity score-matched ACLF cohort. Mechanical ventilation and pulmonary failure were identified as independent risk factors for increased short-term mortality. In matched ACLF patients, the presence of pulmonary failure showed the highest 28-day mortality (83.7%), whereas mortality rates in ACLF with mechanical ventilation (67.3%) and ACLF without pulmonary impairment (38.8%) were considerably lower (p < .001). Especially in patients with pulmonary impairment, the CLIF-C ACLF score showed poor predictive accuracy. Adjusting the CLIF-C ACLF score for the grade of pulmonary impairment improved the prediction significantly. This study highlights that not only pulmonary failure but also mechanical ventilation is associated with worse prognosis in ACLF patients. The grade of pulmonary impairment should be considered in the risk assessment in ACLF patients. The new score may be useful in the selection of patients for liver transplantation.

Sections du résumé

BACKGROUND & AIMS
In ACLF patients, an adequate risk stratification is essential, especially for liver transplant allocation, since ACLF is associated with high short-term mortality. The CLIF-C ACLF score is the best prognostic model to predict outcome in ACLF patients. While lung failure is generally regarded as signum malum in ICU care, this study aims to evaluate and quantify the role of pulmonary impairment on outcome in ACLF patients.
METHODS
In this retrospective study, 498 patients with liver cirrhosis and admission to IMC/ICU were included. ACLF was defined according to EASL-CLIF criteria. Pulmonary impairment was classified into three groups: unimpaired ventilation, need for mechanical ventilation and defined pulmonary failure. These factors were analysed in different cohorts, including a propensity score-matched ACLF cohort.
RESULTS
Mechanical ventilation and pulmonary failure were identified as independent risk factors for increased short-term mortality. In matched ACLF patients, the presence of pulmonary failure showed the highest 28-day mortality (83.7%), whereas mortality rates in ACLF with mechanical ventilation (67.3%) and ACLF without pulmonary impairment (38.8%) were considerably lower (p < .001). Especially in patients with pulmonary impairment, the CLIF-C ACLF score showed poor predictive accuracy. Adjusting the CLIF-C ACLF score for the grade of pulmonary impairment improved the prediction significantly.
CONCLUSIONS
This study highlights that not only pulmonary failure but also mechanical ventilation is associated with worse prognosis in ACLF patients. The grade of pulmonary impairment should be considered in the risk assessment in ACLF patients. The new score may be useful in the selection of patients for liver transplantation.

Identifiants

pubmed: 35727853
doi: 10.1111/liv.15343
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

180-193

Informations de copyright

© 2022 The Authors. Liver International published by John Wiley & Sons Ltd.

Références

Arroyo V, Moreau R, Jalan R, Ginès P. Acute-on-chronic liver failure: a new syndrome that will re-classify cirrhosis. J Hepatol. 2015;62(S1):S131-S143. doi:10.1016/j.jhep.2014.11.045
Arroyo V, Moreau R, Jalan R. Acute-on-chronic liver failure. N Engl J Med. 2020;382(22):2137-2145. doi:10.1056/NEJMra1914900
Trebicka J, Fernandez J, Papp M, et al. PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis. J Hepatol. 2020;S0168-8278(20):33772-33777. doi:10.1016/j.jhep.2020.11.019
Engelmann C, Thomsen KL, Zakeri N, et al. Validation of CLIF-C ACLF score to define a threshold for futility of intensive care support for patients with acute-on-chronic liver failure. Crit Care. 2018;22:254. doi:10.1186/s13054-018-2156-0
Barosa R, Roque-Ramos L, Patita M, Nunes G, Fonseca J. CLIF-C ACLF score is a better mortality predictor than MELD, MELD-Na and CTP in patients with acute on chronic liver failure admitted to the ward. Rev Esp Enfermedades Dig. 2017;109(6):399-405. doi:10.17235/reed.2017.4701/2016
Ramzan M, Iqbal A, Murtaza HG, Javed N. Comparison of CLIF-C ACLF score and MELD score in predicting ICU mortality in patients with acute-on-chronic liver failure. Objective. 2020;12(2):e7087. doi:10.7759/cureus.7087
Gustot T, Fernandez J, Garcia E, et al. Clinical course of acute-on-chronic liver failure syndrome and effects on prognosis. Hepatology. 2015 Jul;62(1):243-252. doi:10.1002/hep.27849.8
Moreau R, Jalan R, Gines P, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. YGAST. 2013;144(7):1426-1437.e9. doi:10.1053/j.gastro.2013.02.042
Trebicka J, Sundaram V, Moreau R. Liver transplantation for acute-on- chronic liver failure: science or fiction? Liver Transpl. 2020;26(7):906-915. doi:10.1002/lt.25788
Hernaez R, Solà E, Moreau R, Ginès P. Acute-on-chronic liver failure: an update. Gut. 2017;66(3):541-553. doi:10.1136/gutjnl-2016-312670
Levesque E, Saliba F, Ichaï P, Samuel D. Outcome of patients with cirrhosis requiring mechanical ventilation in ICU. J Hepatol. 2014;60(3):570-578. doi:10.1016/j.jhep.2013.11.012
Jalan R, Saliba F, Pavesi M, et al. Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure. J Hepatol. 2014;61(5):1038-1047. doi:10.1016/j.jhep.2014.06.012
Trebicka J, Fernandez J, Papp M, et al. The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology. J Hepatol. 2020;842-854:842-854. doi:10.1016/j.jhep.2020.06.013
Ginès P, Fernández J, Durand F, Saliba F. Management of critically-ill cirrhotic patients. J Hepatol. 2012;56:S13-S24. doi:10.1016/S0168-8278(12)60003-8
Saliba F, Ichaı P, Levesque E, Samuel D. Cirrhotic patients in the ICU: prognostic markers and outcome. Curr Opin Crit Care. 2013;19(2):154-60. doi:10.1097/MCC.0b013e32835f0c17
Sundaram V, Kogachi S, Wong RJ, et al. Effect of the clinical course of acute-on-chronic liver failure prior to liver transplantation on post-transplant survival. J Hepatol. 2020;72(3):481-488. doi:10.1016/j.jhep.2019.10.013
Mezzano G, Juanola A, Cardenas A, Mezey E, Hamilton JP, Pose E, Graupera I, Ginès P, Solà E, Hernaez R Global burden of disease: acute-on-chronic liver failure, a systematic review and meta-analysis. Gut 2021;gutjnl-2020-322161. doi: 10.1136/gutjnl-2020-322161 Online Ahead of Print, 71, 148, 155
Rabe C, Schmitz V, Paashaus M, et al. Does intubation really equal death in cirrhotic patients? Factors influencing outcome in patients with liver cirrhosis requiring mechanical ventilation. Intensive Care Med. 2004;30(8):1564-1571. doi:10.1007/s00134-004-2346-x
Picon RV, Bertol FS, Tovo CV, de Mattos ÂZ. Chronic liver failure-consortium acute-on-chronic liver failure and acute decompensation scores predict mortality in Brazilian cirrhotic patients. World J Gastroenterol. 2017;23(28):5237-5245. doi:10.3748/wjg.v23.i28.5237
Moreau R, Jalan R, Arroyo V. Acute-on-chronic liver failure: recent concepts. J Clin Exp Hepatol. 2014;5(1):81-85. doi:10.1016/j.jceh.2014.09.003
Drolz A, Horvatits T, Rutter K, et al. Lactate improves prediction of short-term mortality in critically ill patients with cirrhosis: a multinational study. Hepatology. 2019;69(1):258-269. doi:10.1002/hep.30151

Auteurs

Martin S Schulz (MS)

Department of Internal Medicine I, Goethe University, Frankfurt, Germany.
Department of Internal Medicine B, University of Münster, Münster, Germany.

Jan Mengers (J)

Department of Internal Medicine I, Goethe University, Frankfurt, Germany.

Wenyi Gu (W)

Department of Internal Medicine I, Goethe University, Frankfurt, Germany.
Department of Internal Medicine B, University of Münster, Münster, Germany.

Andreas Drolz (A)

1st Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Philip G Ferstl (PG)

Department of Internal Medicine I, Goethe University, Frankfurt, Germany.

Alex Amoros (A)

European Foundation for Study of Chronic Liver Failure, EF-Clif, Barcelona, Spain.

Frank E Uschner (FE)

Department of Internal Medicine I, Goethe University, Frankfurt, Germany.
Department of Internal Medicine B, University of Münster, Münster, Germany.

Nora Ackermann (N)

Department of Internal Medicine I, Goethe University, Frankfurt, Germany.

Georg Guttenberg (G)

Department of Internal Medicine I, Goethe University, Frankfurt, Germany.

Alexander Queck (A)

Department of Internal Medicine I, Goethe University, Frankfurt, Germany.

Maximilian J Brol (MJ)

Department of Internal Medicine I, Goethe University, Frankfurt, Germany.
Department of Internal Medicine B, University of Münster, Münster, Germany.

Christiana Graf (C)

Department of Internal Medicine I, Goethe University, Frankfurt, Germany.

Philipp Stoffers (P)

Department of Internal Medicine I, Goethe University, Frankfurt, Germany.

Anna-Lena Laguna de la Vera (AL)

Department of Internal Medicine I, Goethe University, Frankfurt, Germany.

Carla Cremonese (C)

Department of Internal Medicine I, Goethe University, Frankfurt, Germany.

Hans-Peter Erasmus (HP)

Department of Internal Medicine I, Goethe University, Frankfurt, Germany.

Martin W Welker (MW)

Department of Internal Medicine I, Goethe University, Frankfurt, Germany.

Achim Grünewaldt (A)

Department of Internal Medicine I, Goethe University, Frankfurt, Germany.

Vincente Arroyo (V)

European Foundation for Study of Chronic Liver Failure, EF-Clif, Barcelona, Spain.

Jörg Bojunga (J)

Department of Internal Medicine I, Goethe University, Frankfurt, Germany.

Javier Fernandez (J)

European Foundation for Study of Chronic Liver Failure, EF-Clif, Barcelona, Spain.
Hospital Clinic of Barcelona, University of Barcelona, CIBEReHD, IDIBAPS, Barcelona, Spain.

Stefan Zeuzem (S)

Department of Internal Medicine I, Goethe University, Frankfurt, Germany.

Johannes Kluwe (J)

1st Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Kai-Hendrik Peiffer (KH)

Department of Internal Medicine I, Goethe University, Frankfurt, Germany.

Christoph Welsch (C)

Department of Internal Medicine I, Goethe University, Frankfurt, Germany.

Valentin Fuhrmann (V)

Department of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Gernot Rohde (G)

Department of Internal Medicine I, Goethe University, Frankfurt, Germany.

Jonel Trebicka (J)

Department of Internal Medicine I, Goethe University, Frankfurt, Germany.
Department of Internal Medicine B, University of Münster, Münster, Germany.
European Foundation for Study of Chronic Liver Failure, EF-Clif, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH